Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve.

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Patients can use Ozempic as a rapid weight-loss drug. A result of quick weight loss is sagging, aging skin, most noticeably ...

The diabetes medication Ozempic has emerged as an unexpected player in the weight loss arena, sparking intense ...

Pamela Anderson’s head-turning appearance at the Baftas in a low-cut gown proved that even midlifers can take on this ...

The former glamour model, 45, has gone under the knife for a long list of procedures, most recently jetting to Turkey to have ...

Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and ...

Cleveland Clinic experts reveals what's behind "Ozempic face," and list the semaglutide-associated symptoms that can call for ...

“The first thing they see is the loose skin on their abdomen," says R. Brannon Claytor, a Bryn Mawr, Pa.-based plastic ...

Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging ...

Those who lose weight on Ozempic often find success has left them with sagging skin—a common side effect that is driving a boom in cosmetic surgery. Plastic surgeons say they have long had patients ...